KODIAK SCIENCES INC. Capital Expenditures
KODIAK SCIENCES INC. (KOD) reported Capital Expenditures of $1.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $352.00K, a 164.66% increase year-over-year.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $942.00K, a 248.89% increase year-over-year.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $43.00K, a 65.32% decline year-over-year.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $60.00K, a 66.67% decline year-over-year.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for fiscal 2025 was $506.00K, a 34.93% increase from fiscal 2024.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for fiscal 2024 was $375.00K, a 99.09% decline from fiscal 2023.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for fiscal 2023 was $41.35M, a 11.69% increase from fiscal 2022.
- KODIAK SCIENCES INC. payments to acquire property, plant, and equipment for fiscal 2022 was $37.02M, a 117.36% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.29M 10-Q · filed 2026-08-13 | $1.34M derived: sum of 3 quarters · filed 2026-08-13 | $1.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $942.00K 10-Q · filed 2026-05-07 | $985.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.04M derived: sum of 3 quarters · filed 2026-05-07 | $1.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $103.00K derived: sum of 2 quarters · filed 2026-03-31 | $236.00K derived: sum of 3 quarters · filed 2026-08-13 | $506.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $193.00K derived: sum of 2 quarters · filed 2026-08-13 | $463.00K 10-Q · filed 2025-11-13 | $587.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $403.00K 10-Q · filed 2026-08-13 | $527.00K derived: sum of 3 quarters · filed 2026-08-13 | $707.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $270.00K 10-Q · filed 2026-05-07 | $394.00K derived: sum of 2 quarters · filed 2026-05-07 | $574.00K derived: sum of 3 quarters · filed 2026-05-07 | $623.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $304.00K derived: sum of 2 quarters · filed 2026-03-31 | $353.00K derived: sum of 3 quarters · filed 2026-03-31 | $375.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $229.00K derived: sum of 2 quarters · filed 2025-11-13 | $251.00K 10-Q · filed 2025-11-13 | $27.73M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $71.00K 10-Q · filed 2025-08-13 | $27.55M derived: sum of 3 quarters · filed 2026-03-31 | $27.78M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | $22.00K 10-Q · filed 2025-05-14 | $27.51M derived: sum of 2 quarters · filed 2026-03-31 | $27.73M derived: sum of 3 quarters · filed 2026-03-31 | $29.20M derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | $27.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $27.71M derived: sum of 2 quarters · filed 2026-03-31 | $29.18M derived: sum of 3 quarters · filed 2026-03-31 | $41.35M 10-K · filed 2026-03-31 |
| 2023-09-30 | $226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.70M derived: sum of 2 quarters · filed 2024-11-14 | $13.87M 10-Q · filed 2024-11-14 | $16.93M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $13.64M 10-Q · filed 2024-08-14 | $16.70M derived: sum of 3 quarters · filed 2025-03-27 | $24.97M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | $12.17M 10-Q · filed 2024-05-15 | $15.23M derived: sum of 2 quarters · filed 2025-03-27 | $23.50M derived: sum of 3 quarters · filed 2025-03-27 | $31.73M derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $11.33M derived: sum of 2 quarters · filed 2025-03-27 | $19.56M derived: sum of 3 quarters · filed 2025-03-27 | $37.02M 10-K · filed 2025-03-27 |
| 2022-09-30 | $8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $16.50M derived: sum of 2 quarters · filed 2023-11-14 | $33.96M 10-Q · filed 2023-11-14 | $42.39M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $8.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $25.69M 10-Q · filed 2023-08-14 | $34.12M derived: sum of 3 quarters · filed 2024-03-28 | $38.95M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $17.46M 10-Q · filed 2023-05-15 | $25.89M derived: sum of 2 quarters · filed 2024-03-28 | $30.72M derived: sum of 3 quarters · filed 2024-03-28 | $33.26M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $13.26M derived: sum of 2 quarters · filed 2024-03-28 | $15.79M derived: sum of 3 quarters · filed 2024-03-28 | $17.03M 10-K · filed 2024-03-28 |
| 2021-09-30 | $4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.36M derived: sum of 2 quarters · filed 2022-11-09 | $8.60M 10-Q · filed 2022-11-09 | $10.56M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.77M 10-Q · filed 2022-08-09 | $5.73M derived: sum of 3 quarters · filed 2023-03-28 | $7.34M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-10 | $3.20M derived: sum of 2 quarters · filed 2023-03-28 | $4.80M derived: sum of 3 quarters · filed 2023-03-28 | $4.87M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.56M derived: sum of 2 quarters · filed 2023-03-28 | $3.63M derived: sum of 3 quarters · filed 2023-03-28 | $3.81M 10-K · filed 2023-03-28 |
| 2020-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.68M derived: sum of 2 quarters · filed 2021-11-09 | $1.85M 10-Q · filed 2021-11-09 | $2.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $249.00K 10-Q · filed 2021-08-09 | $402.00K derived: sum of 3 quarters · filed 2022-03-01 | $560.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $180.00K 10-Q · filed 2021-05-10 | $333.00K derived: sum of 2 quarters · filed 2022-03-01 | $491.00K derived: sum of 3 quarters · filed 2022-03-01 | $610.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $311.00K derived: sum of 2 quarters · filed 2022-03-01 | $430.00K derived: sum of 3 quarters · filed 2022-03-01 | $437.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $277.00K derived: sum of 2 quarters · filed 2020-11-09 | $284.00K 10-Q · filed 2020-11-09 | $306.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $126.00K 10-Q · filed 2020-08-10 | $148.00K derived: sum of 3 quarters · filed 2021-03-01 | $166.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $7.00K 10-Q · filed 2020-05-11 | $29.00K derived: sum of 2 quarters · filed 2021-03-01 | $47.00K derived: sum of 3 quarters · filed 2021-03-01 | $85.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $40.00K derived: sum of 2 quarters · filed 2021-03-01 | $78.00K derived: sum of 3 quarters · filed 2021-03-01 | $78.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $56.00K derived: sum of 2 quarters · filed 2019-11-12 | $56.00K 10-Q · filed 2019-11-12 | $106.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $38.00K 10-Q · filed 2019-08-14 | $88.00K derived: sum of 3 quarters · filed 2020-03-16 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 | $50.00K derived: sum of 2 quarters · filed 2020-03-16 | ||
| 2017-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $209.00K 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $159.00K 10-Q · filed 2018-11-16 | |||
| 2016-12-31 | $771.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |